Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3960 results

Sort By:

Intrauterine Balloon (Bakri©) Versus Uterine Tamponade With Chitosan Gauze (Celox PPH©) in the Management of Postpartum Hemorrhage Refractory to Medical Treatmen

Study ID: NCT06996808
Start Date: 2025-09-01
End Date: 2029-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

196

Intervention / Treatment

Goat balloon

Celox gauze

Sponsor

University of Rome La Sapienza

Source: clinicaltrials.gov

Share:
Add to list

Bone Stimulator for Spondylolysis

Study ID: NCT06666608
Start Date: 2025-12
End Date: 2029-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

48

Intervention / Treatment

Bone Stimulator

Standard of Care Spondylolysis Treatment

Sponsor

The Methodist Hospital Research Institute

Source: clinicaltrials.gov

Share:
Add to list

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

Study ID: NCT04579523
Start Date: 2025-09-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Allogeneic Hematopoietic Stem Cell Transplantation

Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10

Cyclophosphamide

Fludarabine Phosphate

Total-Body Irradiation

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

X-Ray Imaging

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus

Study ID: NCT06913023
Start Date: 2026-01-05
End Date: 2027-11-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

74

Intervention / Treatment

Semaglutide 3 MG [Rybelsus]

Semaglutide 7 MG [Rybelsus]

Semaglutide 14 MG [Rybelsus]

Placebo Oral Tablet

Sponsor

University Health Network, Toronto

Source: clinicaltrials.gov

Share:
Add to list

Assessing Perceptual Effects of Interactive Tasks

Study ID: NCT06828523
Start Date: 2027-10-01
End Date: 2029-02-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1300

Intervention / Treatment

Listener judgements of speech produced in different tasks

Sponsor

Penn State University

Source: clinicaltrials.gov

Share:
Add to list

Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment

Study ID: NCT06948838
Start Date: 2025-09
End Date: 2029-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

16895

Intervention / Treatment

RBPM

MII

Sponsor

Boston Medical Center

Source: clinicaltrials.gov

Share:
Add to list

The Volunteering-in-Place Program for Apathetic Assisted Living Residents With ADRD

Study ID: NCT06735950
Start Date: 2025-09
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

110

Intervention / Treatment

Volunteering in Place Program

Recreational activity

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Sex Differences in Glucose Metabolism in Response to Sleep Curtailment

Study ID: NCT06809023
Start Date: 2025-07
End Date: 2029-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

32

Intervention / Treatment

Sleep restriction

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Group Advanced Care Planning Pilot for Veterans

Study ID: NCT06646614
Start Date: 2025-12-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Group Advance Care Planning Education

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Study of S1B-408 in Women With Orgasmic Dysfunction

Study ID: NCT06516055
Start Date: 2025-07-01
End Date: 2027-03-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

S1B-408

Sponsor

S1 Biopharma, Inc.

Source: clinicaltrials.gov

Share:
Add to list